Arkansas
Arkansas
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Arkansas
Economic Impact
$4.8B
Total output supported by biopharmaceutical sector
$257.1M
Tax Revenue Generated
16,179
Total Jobs
2,838
Direct Jobs
382
Total Clinical Trials
$109 million
Invested in Clinical Trials
6,386
Total Economic Impact of Clinical Trial Investments
$265 million
Invested in Clinical Trials
Programs and Initiatives in Your State: Arkansas
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Building Research Capacity and/or R&D Infrastructure
- Economic Innovation Incentives
- STEM Education & Workforce Development
- Targeted Strategies
- Venture Financing